Fox 29/News 4: Clinical trials to benefit patients

January 30, 2020

Dr. Chethan Ramamurthy, assistant professor of genitourinary (GU) medical oncology for Mays Cancer Center, educates the public on what clinical trials are, the impact and benefits of having patients enroll, and how the Mays Cancer Center is at the forefront of groundbreaking research in our community and beyond.

OncLive: Dr. Ruben Mesa on JAK inhibitors in the pipeline for myelofibrosis

January 29, 2020

Ruben A. Mesa, M.D., director of Mays Cancer Center at the newly named UT Health San Antonio MD Anderson Cancer Center, discusses the approval of fedratinib (Inrebic) in myelofibrosis and other JAK inhibitors in the treatment pipeline. Read the full story at OncLive

Targeted Oncology: Highlighting current advances for the treatment of myeloproliferative neoplasms

January 28, 2020

Ruben Mesa discusses the current state of the treatment landscape for patients with myeloproliferative neoplasms (MPNs).

AJMC: Dr. Ruben Mesa outlines the quality of life impact of myelofibrosis

January 27, 2020

Ruben Mesa, MD, director of Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the impact myelofibrosis has on patients’ quality of life while at the American Society of Hematology conference.

News 4: Treatment for veterans suffering from PTSD following Hurricane Harvey devastation

January 27, 2020

UT Health San Antonio has launched an intensive out-patient program for veterans suffering from post-traumatic stress disorder following the devastation caused by Hurricane Harvey.